PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
PTCT
Valuace
61
Růst
55
Zdraví
75
Cena
$ 70.79
Dnes
--3.16 (-4.18%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
5.7B
Obrat
2B
Zisk
1B
Aktiva
3B
Dluh
2B
ROE
0%
ROA
0%
PE
8
PS
3
Cena 1R
36-88
⌀ Cena
58.61
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
23-04-2026
Poslední dividenda

Profil

PTC Therapeutics, Inc., biofarmaceutická společnost, se zaměřuje na objevování, vývoj a komercializaci léčiv pro pacienty se vzácnými poruchami. Jeho portfolio potrubí zahrnuje komerční produkty a kandidáty na produkty v různých fázích vývoje, včetně klinických, předklinických a výzkumných a objevných fází, se zaměřuje na vývoj léčby pro více terapeutických oblastí, jako jsou vzácná onemocnění. Společnost nabízí přípravek Translarna a Emflaza k léčbě svalové dystrofie Duchenne v Evropském hospodářském prostoru a ve Spojených státech, stejně jako k léčbě nesmyslné mutace svalové dystrofie Duchenne v Brazílii a Rusku, komercializuje Tegsedi a Waylivru pro léčbu vzácných onemocnění v Latinské Americe a Karibiku a uvádí na trh přípravek Evrysdi pro léčbu svalové atrofie páteře u dospělých a dětí ve věku dvou měsíců a starších v Brazílii. Platforma společnosti pro splicing zahrnuje PTC518, která je vyvíjena pro léčbu Huntingtonovy choroby. PTC Therapeutics, Inc. spolupracuje s F. Hoffman-La Roche Ltd a Hoffman-La Roche Inc., jakož i Spinal Muscular Atrophy Foundation na rozvoji výzkumu v oblasti regenerativní medicíny a Akcea Therapeutics, Inc. na komercializaci Tegsedi a Waylivra pro léčbu vzácných onemocnění v Latinské Americe a Karibiku. PTC Therapeutics, Inc. byla založena v roce 1998 a sídlí v South Plainfield v New Jersey.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
939
Založení
2013-06-20
Adresa
100 Corporate Court
CEO
Matthew B. Klein F.A.C.S.,

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014201320122011
Total Revenues1,730.71,730.7806.8937.8698.8538.6380.8307.0264.7194.482.736.823.031.328.899.0
Cost of Revenues156.571.857.465.544.732.318.912.112.74.60.00.0-2.3-3.4-5.20.0
Gross Profit1,574.11,658.9749.4872.3654.1506.3361.8294.8252.1189.882.736.825.234.733.999.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues164.7211.0178.91,176.1213.2196.8186.7210.1307.1196.6
Cost of Revenues16.3115.911.412.916.310.815.514.7106.39.5
Gross Profit148.495.1167.51,163.2196.9185.9171.2195.4200.8187.1
Operating Income TTM 202520242023202220212020201920182017201620152014201320122011
R&D Expenses0.00.00.0666.6651.5540.7477.6257.5172.0117.5117.6121.879.854.946.158.7
Selling General & Admin Expenses0.00.00.0332.5326.0285.8245.2202.5153.5121.397.182.144.825.214.616.2
Depreciation & Amortization38.838.875.7236.667.3-3.1170.176.022.915.43.32.92.22.42.72.9
Total Operating Expenses717.5802.41,052.01,311.81,094.0881.2759.7487.6348.4254.1214.8203.9122.476.755.668.4
Operating Income856.7856.5-302.6-349.4-439.9-374.9-397.9-192.8-115.7-64.3-132.1-167.1-99.4-45.4-26.830.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.0121.4164.2
Selling General & Admin Expenses0.00.00.00.00.00.00.00.076.380.9
Depreciation & Amortization12.911.17.67.26.86.57.055.480.764.5
Total Operating Expenses230.092.1202.4193.0359.3240.4211.4240.8197.6305.2
Operating Income-81.63.0-35.0970.2-162.4-54.5-40.2-45.53.1-118.2
Net Income TTM 202520242023202220212020201920182017201620152014201320122011
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Interest Expense152.2152.2167.0129.290.986.056.4-12.5-12.6-12.1-8.3-2.41.20.00.00.0
Other Expense-160.0-159.9-60.5-346.7-147.6-143.4-5.1-47.1-19.2-1.3-1.2-0.5-0.2-0.11.80.5
IBT696.6696.6-363.1-696.1-587.5-518.3-402.9-239.9-128.1-77.7-141.5-170.0-98.4-51.6-26.228.6
Income Tax Expense14.014.00.2-69.5-28.55.635.211.70.01.30.60.5-4.76.21.2-2.3
Net Income682.6682.6-363.3-626.6-559.0-523.9-438.2-251.6-128.1-79.0-142.1-170.4-93.8-51.6-26.230.9
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.028.2
Interest Expense55.232.630.434.141.141.643.540.844.328.2
Other Expense-57.5-26.1-36.1-40.467.7-43.5-45.5-39.2-160.2-48.4
IBT-139.1-23.1-71.1929.8-94.7-98.0-85.7-84.7-157.1-166.6
Income Tax Expense-4.1-39.0-6.263.3-28.88.713.46.9-1.3-33.6
Net Income-135.015.9-64.8866.6-65.9-106.7-99.2-91.6-155.8-133.0
Per Share Data TTM 202520242023202220212020201920182017201620152014201320122011
EPS$0.00$0.00$0.00$-8.37$-7.79$-7.43$-6.64$-4.27$-2.75$-2.02$-4.17$-5.07$-2.97$-4.02$-1.85$0.00
EPS Diluted$0.00$0.00$0.00$-8.37$-7.79$-7.43$-6.64$-4.27$-2.75$-2.02$-4.17$-5.07$-2.97$-4.02$-1.11$0.00
Shares Outstanding80.779.576.874.871.770.566.058.946.639.234.033.631.612.814.214.2
Diluted Shares Outstanding80.788.376.874.871.770.566.058.946.639.234.033.631.612.823.723.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-2.06$-1.76
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-2.06$-1.76
Shares Outstanding80.781.578.278.177.276.976.776.575.575.4
Diluted Shares Outstanding80.787.178.286.477.276.976.776.575.575.4
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents654.8779.7594.0410.7773.4208.8686.6227.6191.2231.7338.9315.215.42.728.4
Short Term Investments438.5360.0282.7130.9583.7894.8398.558.179.5173.3280.9265.5127.10.00.0
Total Cash & ST Investments1,093.31,139.7876.7410.7773.41,103.7686.6227.6191.2231.7338.9315.2142.52.728.4
Accounts Receivable187.2158.6161.0155.6110.569.955.567.940.424.911.14.41.01.01.2
Inventory31.823.230.621.815.918.719.316.110.80.00.00.00.00.00.0
Other Current Assets45.644.1150.3105.7-126.339.517.99.26.74.75.93.91.60.93.4
Total Current Assets1,357.91,365.51,218.6693.8773.41,231.7779.3320.9249.1261.3355.9323.6145.04.633.1
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents672.61,017.41,480.2779.7526.0654.8548.4594.0165.2208.4
Short Term Investments1,034.7971.8547.0360.0487.4438.5336.5282.7129.7129.6
Total Cash & ST Investments1,707.31,989.22,027.21,139.71,013.41,093.3884.8876.7294.8337.9
Accounts Receivable203.1196.1210.5158.6200.0187.2197.7161.0165.7177.5
Inventory52.734.121.723.235.731.830.130.635.832.0
Other Current Assets44.753.557.144.132.545.656.2150.344.142.2
Total Current Assets2,007.82,272.92,316.41,365.51,281.61,357.91,168.71,218.6540.4589.7
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment123.1117.7179.0175.0130.0118.221.512.78.47.49.09.26.78.310.8
Goodwill82.382.382.382.382.382.382.382.30.00.00.00.00.00.00.0
Intangible Assets329.9118.8379.5705.9724.8715.3710.5701.0133.00.00.00.00.00.00.0
Long-Term Investments13.80.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets9.320.736.248.6227.560.630.12.31.20.63.10.50.10.20.3
Total Long-Term Assets558.4339.5677.11,011.81,164.7976.5844.5798.4142.68.112.19.66.98.511.1
Total Assets1,916.41,705.01,895.71,705.61,938.12,208.31,623.81,119.2391.7269.3368.0333.2151.913.144.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment137.7113.4116.8117.7122.6123.1184.0179.0179.1178.8
Goodwill82.382.382.382.382.382.382.382.382.382.3
Intangible Assets396.5143.8118.4118.8330.4329.9330.0379.5423.3451.6
Long-Term Investments0.00.00.00.00.00.00.016.316.316.1
Other Long-Term Assets19.421.821.420.725.323.124.520.034.735.6
Total Long-Term Assets635.9361.3339.0339.5560.7558.4620.9684.6719.5748.4
Total Assets2,643.72,634.22,655.41,705.01,842.21,916.41,789.61,903.21,259.91,338.1
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable24.317.36.027.323.018.710.36.015.36.311.94.11.10.61.9
Short-Term Debt16.0271.2210.312.4159.88.720.011.761.240.90.00.00.04.47.1
Other Current Liabilities565.8282.3385.9365.260.8245.8197.3145.41.70.933.325.011.16.411.2
Current Liabilities609.8581.0603.1406.2509.3277.3235.9166.882.049.645.432.513.128.243.1
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable36.626.515.217.313.324.327.56.019.225.7
Short-Term Debt561.417.116.5271.216.816.016.5210.328.624.9
Other Current Liabilities268.2534.5486.3282.3574.7565.8528.7385.9440.3414.6
Current Liabilities866.2627.8595.4581.0610.7609.8574.5603.1492.1476.3
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt284.82,199.92,018.8691.3431.4411.7293.9141.3145.098.294.60.00.00.44.5
Capital Leases94.7103.9130.8131.9103.9111.30.00.00.00.00.00.00.00.00.0
Def. Tax Liability55.90.00.0102.8137.1136.7130.9122.0-3.90.0-0.10.00.00.4214.4
Total Liabilities2,896.52,803.12,714.32,052.71,936.61,726.31,029.5768.5235.2149.869.634.815.432.3282.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt1,930.6371.1373.12,199.9383.5379.5404.92,018.8690.0690.3
Capital Leases123.8102.2103.9103.9115.1110.7136.9114.8131.2130.0
Def. Tax Liability0.00.00.00.055.955.955.963.451.951.9
Total Liabilities2,799.52,840.72,841.12,803.12,896.62,896.52,683.52,721.71,930.71,917.4
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock0.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0
Retained Earnings-3,474.3-3,646.9-3,283.6-2,657.0-2,098.0-1,628.9-1,190.5-938.9-814.1-735.1-593.0-422.6-328.8-277.2-250.6
Comprehensive Income-16.5-25.9-1.34.8-24.3-61.0-10.61.54.0-1.5-1.2-0.70.1-20.3-17.6
Total Common Equity-980.2-1,098.1-818.6-347.11.4482.0594.3350.7156.4119.6298.5298.5136.5-19.2-238.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-2,829.3-2,845.2-2,780.3-3,646.9-3,581.0-3,474.3-3,375.2-3,283.6-3,127.8-2,994.8
Comprehensive Income5.97.4-13.9-25.9-4.3-16.5-5.6-1.39.6-1.4
Total Common Equity-155.8-206.5-185.8-1,098.1-1,054.4-980.2-893.9-818.6-670.8-579.3
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt395.52,471.12,229.1703.6431.4420.4313.9153.0145.098.294.60.00.04.911.7
Book Value-980.2-1,098.1-818.6-347.11.4482.0594.3350.7156.4119.6298.5298.5136.5-19.2-238.6
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-155.8-206.5-185.8-1,098.1-1,054.4-980.2-893.9-818.6-670.8-579.3
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017201620152014201320122011
Net Income-479.5682.6-363.3-626.6-559.0-523.9-438.2-251.6-128.1-79.0-142.1-170.4-93.8-51.6-26.230.9
Depreciation & Amortization205.238.875.7236.6128.864.184.932.226.117.73.32.92.22.42.72.9
Stock-Based Compensation110.60.074.6131.2110.3103.570.342.133.330.635.034.019.38.42.32.8
Change Working Capital-20.8-52.6102.5-4.0-85.3-23.836.920.414.213.2-9.04.713.2-12.3-25.1-57.3
Change In Accounts Receivable-14.8-10.21.7-1.5-48.5-45.0-10.511.5-29.6-12.2-14.8-6.9-3.50.00.00.0
Change In Accounts Payable-2.90.00.048.327.523.453.613.743.124.04.317.016.95,183.40.00.0
Change In Inventories-0.2-53.96.2-8.2-6.71.81.8-3.5-5.8-6.50.9-2.0-2.60.00.00.0
Other Non-cash Items260.642.358.7151.382.8128.346.149.427.47.39.42.321.06.00.20.4
Cash from Operations-115.50.00.0-158.4-356.7-251.3-194.1-98.6-27.6-10.1-103.6-124.3-57.3-46.9-47.9-20.8
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-135.015.9-64.8866.6-65.9-106.7-99.2-91.6-155.8-133.0
Depreciation & Amortization12.911.17.67.26.86.57.055.480.762.1
Stock-Based Compensation0.019.418.518.117.219.819.218.416.556.5
Change Working Capital91.1-84.9-16.7-37.436.611.6-11.265.5-82.67.5
Change In Accounts Receivable22.2-6.521.9-47.840.8-7.78.2-39.58.38.1
Change In Accounts Payable0.00.00.00.00.00.00.00.00.02.5
Change In Inventories-26.8-18.5-10.82.211.1-3.1-1.90.15.9-4.3
Other Non-cash Items-3.3-27.9-2.915.731.2-8.212.623.136.9-7.6
Cash from Operations0.00.00.00.00.00.00.00.0-100.3-14.5
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Capital Expenditure-114.6-300.0-6.5-28.4-152.5-85.3-56.0-45.4-15.5-3.1-1.8-2.7-4.7-0.8-0.2-0.2
Acquisitions15.00.10.00.0128.457.138.1-4.0-48.9-77.20.00.00.00.00.00.0
Investments-503.5-1,417.2-667.4-212.5-75.6-543.3-1,449.7-494.1-68.6-81.4-85.4-223.8-247.8-156.00.0-2.0
Sales of Investment285.2855.1607.7156.4518.2847.8944.1156.390.4174.7191.6205.7107.329.10.029.9
Other Investing Activities-92.30.00.0-92.2-128.4-57.1-38.10.00.00.00.00.00.00.00.00.0
Cash from Investing-304.90.00.0-176.7290.2219.2-561.5-387.2-42.613.1104.5-20.8-145.2-127.8-0.227.7
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-37.3-3.4-1.3-1.7-3.8-0.57.4-9.6-28.5-29.2
Acquisitions0.00.00.00.00.00.00.00.0-35.922.8
Investments-319.4-233.6-536.6-327.5-141.1-217.2-195.7-113.4-186.1-8.2
Sales of Investment390.7200.2118.6145.6265.3185.294.462.9120.27.8
Other Investing Activities0.00.00.00.00.00.00.00.035.9-22.8
Cash from Investing0.00.00.00.00.00.00.00.0-94.4-29.6
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Debt Repaid-384.40.00.0-301.4-151.3-2.2-46.2-11.70.00.00.00.00.0-5.0-6.9-7.2
Debt Issued77.32,471.1241.91,826.9423.513.2152.7172.58.046.83.694.60.00.20.118.9
Issuance of Common Stock12.60.00.030.050.00.028.1323.8117.92.50.00.0236.0131.60.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities1,244.70.00.0947.8269.223.1686.8301.113.741.81.0154.11.260.829.40.0
Cash from Financing870.90.00.0646.4168.020.9668.7613.2131.644.21.0154.1237.1187.422.4-7.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-381.70.0
Debt Issued2,492.02,103.9-1.4-2,081.52,070.94.7-25.96.492.31.7
Issuance of Common Stock0.00.00.00.00.00.00.00.02.43.4
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.01,002.13.4
Cash from Financing0.00.00.00.00.00.00.00.0620.53.4
Cash position TTM 202520242023202220212020201920182017201620152014201320122011
Net Change in Cash446.5204.9185.0314.498.7-19.1-79.2126.057.753.50.38.334.312.7-25.7-0.2
Closing Cash Balance654.8984.6795.3610.3295.9197.2216.3295.5169.5111.858.358.049.715.42.728.4
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash312.0-344.8-462.8700.5255.5-128.8103.9-45.7428.8-43.1
Closing Cash Balance984.6672.61,033.11,495.9795.3539.8668.5564.6594.0181.4
Free Cash Flow TTM 202520242023202220212020201920182017201620152014201320122011
Free Cash Flow-230.1702.3-181.9-279.0-509.1-336.7-250.0-144.1-43.2-13.2-105.3-127.1-61.9-47.8-48.1-20.9
Real Free Cash Flow-340.8702.3-256.6-410.2-619.4-440.2-320.4-186.2-76.4-43.7-140.4-161.0-81.2-56.2-50.4-23.7
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-36.6-69.7-62.3867.6-36.5-87.8-64.16.4-128.8-43.7
Real Free Cash Flow-36.6-89.2-80.9849.5-53.7-107.5-83.3-12.0-145.3-100.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E7.7-8.2-1.4
P/S314.29.4
P/B-33.841.75.2
P/FCF8.2-11.3-1.5
Market cap$5.7$9.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %22 %0 %
Debt to Income365.1 %-64.5 %0 %
Debt to Free cash flow387.7 %-13147.4 %0 %
Interest expense percentage17.8 %-8.9 %44.7 %
Current ratio2.3 4.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-438.3 %-694.8 %0 %
ROA25.8 %-28.3 %0 %
CapEx to Revenue2.5 %9.5 %0 %
RaD to Revenue0 %138.9 %0 %
ROEM1,730,655.0 301359.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin91 %99.6 %68.7 %
Operating margin49.5 %-131.3 %35.5 %
Net margin39.4 %-139.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding80.7 mil 51.7 mil
Employee count1.0 tis 0.7 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader